Fernandez-Gomez Francisco-Jose, Jumeau Fanny, Derisbourg Maxime, Burnouf Sylvie, Tran Hélène, Eddarkaoui Sabiha, Obriot Hélène, Dutoit-Lefevre Virginie, Deramecourt Vincent, Mitchell Valérie, Lefranc Didier, Hamdane Malika, Blum David, Buée Luc, Buée-Scherrer Valérie, Sergeant Nicolas
Team Alzheimer & Tauopathies, Jean-Pierre Aubert Research Centre, Inserm UMR 837.
Team Alzheimer & Tauopathies, Jean-Pierre Aubert Research Centre, Inserm UMR 837; EA 4308-Department of Reproductive Biology-Spermiology-CECOS, CHRU-Lille.
J Vis Exp. 2014 Apr 10(86):51339. doi: 10.3791/51339.
Two-dimensional gel electrophoresis (2DE) is a powerful tool to uncover proteome modifications potentially related to different physiological or pathological conditions. Basically, this technique is based on the separation of proteins according to their isoelectric point in a first step, and secondly according to their molecular weights by SDS polyacrylamide gel electrophoresis (SDS-PAGE). In this report an optimized sample preparation protocol for little amount of human post-mortem and mouse brain tissue is described. This method enables to perform both two-dimensional fluorescence difference gel electrophoresis (2D-DIGE) and mini 2DE immunoblotting. The combination of these approaches allows one to not only find new proteins and/or protein modifications in their expression thanks to its compatibility with mass spectrometry detection, but also a new insight into markers validation. Thus, mini-2DE coupled to western blotting permits to identify and validate post-translational modifications, proteins catabolism and provides a qualitative comparison among different conditions and/or treatments. Herein, we provide a method to study components of protein aggregates found in AD and Lewy body dementia such as the amyloid-beta peptide and the alpha-synuclein. Our method can thus be adapted for the analysis of the proteome and insoluble proteins extract from human brain tissue and mice models too. In parallel, it may provide useful information for the study of molecular and cellular pathways involved in neurodegenerative diseases as well as potential novel biomarkers and therapeutic targets.
二维凝胶电泳(2DE)是一种强大的工具,可用于揭示可能与不同生理或病理状况相关的蛋白质组修饰。基本上,该技术首先基于蛋白质的等电点进行分离,其次通过SDS聚丙烯酰胺凝胶电泳(SDS-PAGE)根据其分子量进行分离。在本报告中,描述了一种针对少量人类尸检和小鼠脑组织的优化样品制备方案。该方法能够同时进行二维荧光差异凝胶电泳(2D-DIGE)和小型2DE免疫印迹。这些方法的结合不仅使人们能够借助其与质谱检测的兼容性,发现新蛋白质和/或蛋白质表达修饰,还能对标志物验证有新的认识。因此,与蛋白质印迹相结合的小型2DE能够识别和验证翻译后修饰、蛋白质分解代谢,并在不同条件和/或处理之间进行定性比较。在此,我们提供了一种研究在阿尔茨海默病和路易体痴呆中发现的蛋白质聚集体成分的方法,如淀粉样β肽和α-突触核蛋白。因此,我们的方法也可适用于分析从人类脑组织和小鼠模型中提取的蛋白质组和不溶性蛋白质。同时,它可能为研究神经退行性疾病中涉及的分子和细胞途径以及潜在的新型生物标志物和治疗靶点提供有用信息。